Ready 8-Ks
50
Latest filing
May 29, 2026, 4:16 PM ET
Top materiality
0.90
Event mix
earnings ×17 · leadership ×13 · other_material ×9
Sentiment
15 pos · 2 neg · 33 neu
Latest earnings
▼ miss 2026-Q1
-
Ecolab issues $5B in notes to fund CoolIT acquisition and general purposes
Issued $1.2B 4.600% notes due 2029, $900M 4.800% notes due 2031, $1.5B 5.150% notes due 2033, $1.4B 5.350% notes due 2036.
-
Ecolab Q1 adj. EPS $1.70, +13% YoY; maintains FY adj. EPS outlook $8.43-$8.63
Reported sales $4,066M (+10%), organic sales +4%; Life Sciences organic +11% led by bioprocessing.
-
Ecolab enters $4.75B term loan to finance Frigeo acquisition
$4.75B unsecured delayed draw term loan to finance acquisition of Frigeo Holdings and repay its existing debt.
-
Ecolab to acquire CoolIT Systems for $4.75B; updates 2026 EPS guidance
Acquisition of CoolIT Systems for $4.75B cash; expected close Q3 2026, subject to regulatory approvals.
-
Ecolab Q4 adjusted EPS $2.08 (+15%); 2026 guidance $8.43-$8.63 EPS, +12-15%
Q4 reported sales $4.2B (+5%), organic +3%; adjusted diluted EPS $2.08, +15% YoY.
-
Ecolab Q3 adjusted EPS $2.07 (+13% YoY), sales $4.2B (+4%), guides FY25 adjusted EPS $7.48-$7.58
Adjusted diluted EPS $2.07, +13% YoY; reported EPS $2.05 (-21% due to prior year gain on surgical solutions sale).
-
Ecolab issues $500M of 5.000% Notes due 2035; proceeds may fund Ovivo Electronics acquisition
Issued $500M aggregate principal of 5.000% Notes due September 1, 2035.
-
Ecolab Q2 adjusted EPS $1.89, +13% YoY; organic sales +3%; maintains FY2025 guidance
Reported diluted EPS $1.84, adjusted diluted EPS $1.89 (+13% YoY).
-
Ecolab Q1 adjusted EPS $1.50, +12% YoY; organic sales +3%; maintains 2025 EPS guidance $7.42-$7.62
Adjusted diluted EPS $1.50 (+12% YoY); reported diluted EPS $1.41 (-1% YoY).
-
Ecolab Q4 adjusted EPS $1.81, +17%; organic sales +4%; FY2025 EPS guidance $7.42-$7.62
Q4 reported EPS $1.66, adjusted EPS $1.81 (+17%); revenue $4.0B (+2% reported, +4% organic).
-
Ecolab Q3 adj. EPS $1.83, +19% YoY; raises FY2024 guidance to $6.60-$6.70
Adjusted diluted EPS $1.83 (+19% YoY); reported EPS $2.58 (+83% including surgical solutions gain).
-
Ecolab Q2 adj EPS $1.68 (+35% YoY), raises FY2024 outlook to $6.50-$6.70, launches $225M restructuring
Reported sales $3.99B (+3% reported, +4% organic); reported diluted EPS $1.71 (+49%), adjusted $1.68 (+35%).
-
Ecolab Q1 adj EPS $1.34 (+52%); raises FY guide to $6.40-$6.70; sells surgical unit for $950M
Adjusted diluted EPS $1.34, +52% YoY; reported diluted EPS $1.43, +74%.
-
Ecolab Q4 adjusted EPS $1.55 (+22%); FY2024 guidance $6.10-$6.50 (+17-25%)
Q4 reported diluted EPS $1.41, adjusted diluted EPS $1.55 (+22%); revenue $3.9B (+7% reported, +6% organic).
-
Ecolab Q3 adjusted EPS $1.54 (+18%); organic sales +7%; Q4 guidance $1.48-$1.58
Revenue $4.0B (+8% YoY); organic sales +7% led by Institutional & Specialty (+11%) and Pest Elimination.
-
Ecolab Q2 adjusted EPS $1.24, +13% YoY; revenue $3.9B, +8%
Reported diluted EPS $1.15, adjusted $1.24 (+13%); organic sales +9%, organic operating income +21%.
-
Ecolab Q1 organic sales +13%, adj. EPS $0.88 (+7%), guides Q2 $1.15-$1.25
Reported revenue $3.57B (+9% reported, +13% organic); Institutional & Specialty led with 14% organic growth.
-
Ecolab Q4 adjusted EPS $1.27, -1% YoY; expands cost savings program to $175M
Reported sales $3.67B (+9% YoY); adjusted fixed currency sales +12%.
-
Ecolab board authorizes repurchase of up to 10M additional shares
Board authorized repurchase of up to 10,000,000 additional common shares on Nov 3, 2022.
-
Ecolab Q3 adj EPS $1.30 (-6% Y/Y); Europe restructuring charges $130M
Q3 reported sales $3.67B (+10%), adjusted EPS $1.30 (-6% Y/Y); currency translation hurt $0.08.
-
Ecolab Q2 adjusted EPS $1.10, -10% YoY; sales +13% to $3.58B; currency headwinds $0.30/share for FY
Reported EPS $1.08 flat, adjusted EPS $1.10 down 10% YoY; includes $0.06 currency headwind and $0.06 Purolite amort.
-
Ecolab Q1 adjusted EPS $0.82 +1% on 13% sales growth; maintains full-year low-teens EPS growth guidance
Reported sales $3.27B (+13% YoY); acquisition adjusted fixed currency sales +12%.